Efficacy of low dose nivolumab in recurrent / metastatic cervical cancer

被引：1
|
作者：
Devabhaktuni, S. [1 ]
Singh, A. [1 ]
Georgy, J. T. [1 ]
Antonisamy, J. [1 ]
Thumaty, D. B. [1 ]
John, A. O. [1 ]
机构：
[1] CMC Christian Med Coll Hosp, Med Oncol Dept, Vellore, Tamil Nadu, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
286MO
引用
收藏
页码：S1585 / S1585
页数：1
相关论文
共 50 条
  • [31] Tisotumab vedotin in recurrent or metastatic cervical cancer
    Bogani, Giorgio
    Coleman, Robert L.
    Vergote, Ignace
    Raspagliesi, Francesco
    Lorusso, Domenica
    Monk, Bradley J.
    CURRENT PROBLEMS IN CANCER, 2023, 47 (03)
  • [32] Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
    Colombo, Nicoletta
    Dubot, Coraline
    Lorusso, Domenica
    Caceres, M. Valeria
    Hasegawa, Kosei
    Shapira-Frommer, Ronnie
    Tewari, Krishnansu S.
    Salman, Pamela
    Usta, Edwin Hoyos
    Yanez, Eduardo
    Gumus, Mahmut
    de Mendoza, Mivael Olivera Hurtado
    Samouelian, Vanessa
    Castonguay, Vincent
    Arkhipov, Alexander
    Toker, Sarper
    Li, Kan
    Keefe, Stephen M.
    Monk, Bradley J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (01) : 30 - 31
  • [33] Guidelines for the treatment of recurrent and metastatic cervical cancer
    Friedlander, M
    ONCOLOGIST, 2002, 7 (04): : 342 - 347
  • [34] Metastatic urothelial cancer showing an efficacy by low-dose cisplatin
    Matsuyama, H
    Yamakawa, GI
    Hirata, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (05) : 275 - 277
  • [35] Efficacy of Very-Low-Dose Capecitabine in Metastatic Breast Cancer
    Bertelsen, Caitlin
    Ji, Lingyun
    Garcia, Agustin A.
    Russell, Christy
    Spicer, Darcy
    Sposto, Richard
    Tripathy, Debu
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (02) : 20 - 30
  • [36] Efficacy and Safety of Low Dose Vandetanib in Metastatic Medullary Thyroid Cancer
    Modica, R.
    Pizza, G.
    Lo Calzo, F.
    De Cicco, F.
    Sciammarella, C.
    Circelli, L.
    Colao, A.
    Faggiano, A.
    NEUROENDOCRINOLOGY, 2017, 105 : 222 - 222
  • [37] Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell Carcinoma
    Okada, Takuro
    Fushimi, Chihiro
    Matsuki, Takashi
    Okamoto, Isaku
    Sato, Hiroki
    Kondo, Takahito
    Tokashiki, Kunihiko
    Kishida, Takuma
    Ito, Tatsuya
    Yamashita, Gai
    Aihara, Yusuke
    Hanyu, Kenji
    Kushihashi, Yukiomi
    Masubuchi, Tatsuo
    Tada, Yuichiro
    Miura, Kouki
    Harada, Yuki
    Momiyama, Kaho
    Yamashita, Taku
    Omura, G. O.
    Takahashi, Hideaki
    Oridate, Nobuhiko
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2022, 42 (03) : 1607 - 1613
  • [38] Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer
    Fujii, Shota
    Okamoto, Isaku
    Okada, Takuro
    Tokashiki, Kunihiko
    Ueda, Yuri
    Sato, Hiroki
    Ito, Tatsuya
    Tsukahara, Kiyoaki
    ANTICANCER RESEARCH, 2024, 44 (09) : 4085 - 4092
  • [39] Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer
    Ward, Matthew C.
    Shah, Chirag
    Adelstein, David J.
    Geiger, Jessica L.
    Miller, Jacob A.
    Koyfman, Shlomo A.
    Singer, Mendel E.
    ORAL ONCOLOGY, 2017, 74 : 49 - 55
  • [40] THE EFFICACY OF EPIRUBICIN IN RECURRENT CERVICAL-CANCER
    SIVANESARATNAM, V
    SINGAPORE JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1987, 18 (01) : 23 - 26
12345